Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photo Irritation and Sensitivity of Dermacyd Femina Delicata
NCT00705276Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2008
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lactoserum, sponsored by Sanofi. Primary endpoints: Photo irritation and photosensitivity potential at 5 weeks and Sensibility evaluation at 5 weeks. Started Apr 2008; status: completed.
02
Drugs
lactoserum
Beyond the preview
Go deeper on NCT00705276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705276.